CORRECTING and REPLACING etrials Worldwide to Report Third Quarter 2008 Financial...
* Reuters is not responsible for the content in this press release.
CORRECTING and REPLACING etrials Worldwide to Report Third Quarter 2008 Financial Results MORRISVILLE, N.C.--(Business Wire)-- Headline of release should read: etrials Worldwide to Report Third Quarter 2008 Financial Results sted (etrials Worldwide to Report Second Quarter 2008 Financial Results). The release reads: ETRIALS WORLDWIDE TO REPORT THIRD QUARTER 2008 FINANCIAL RESULTS etrials(R) Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services that optimize clinical trial management by turning data into intelligence and shortening the pathway to an actionable study endpoint, announced that it will release financial results for the three months ended September 30, 2008 on Tuesday, November 11, 2008, after the markets close. etrials will also host a conference call at 4:30 p.m. Eastern that day. During the call, Chuck Piccirillo, chief executive officer, and Jay Trepanier, chief financial officer will discuss the company's quarterly performance and financial results. To participate in the live call by telephone, please dial 800-480-2207, or, for international callers, please dial 706-643-7866 and reference ID number 66110811. Those interested in listening to the conference call live via the Internet may do so by visiting the company's web site at www.etrials.com. Please go to the web site 15 minutes prior to the scheduled start to register, download and install any necessary audio software. A web cast audio replay and a telephone audio replay will also be available for two weeks by dialing 800-642-1687 from the US or 706-645-9291 for international callers and entering conference ID number 66110811 when prompted. About etrials(R) etrials Worldwide, Inc. (Nasdaq: ETWC) a leading provider of eClinical software and services to pharmaceutical, biotechnology, medical device, and contract research organizations offers adaptive, Web-based tools that work together to coordinate data capture, logistics, patient interaction and trial management - turning data into intelligence and shortening the pathway to an actionable study endpoint. With global operations, etrials is the only top-tier solutions provider to offer electronic data capture (EDC), interactive voice and Web response (IVR/IWR), electronic patient diaries (eDiary) as part of a flexible and integrated software-as-a-service (SaaS) platform or as individual solutions to capture high quality data from multiple pivot points to enable real-time access for perfectly informed decision-making. As an experienced leader, etrials has facilitated over 900 trials involving more than 400,000 patients in 60 countries; and has participated in 35 studies used for new drug applications. To learn more, visit us at www.etrials.com. etwcf etrials is registered trademark in the United States of etrials Worldwide, Inc. Other marks belong to their respective owners and are used with permission. Media: etrials Chris Sakell, 919-653-3648 Chris.Sakell@etrials.com or Investors: Lippert Heilshorn & Associates Jody Burfening / Amy Gibbons 212-838-3777 agibbons@lhai.com Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters